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(54) METHOD AND APPARATUS FOR OBTAINING CARDIOVASCULAR INFORMATION BY 
MEASURING BETWEEN TWO EXTREMITIES
(57) In this patent of invention there are described a
method and an apparatus for obtaining information on
the cardiovascular system beat by beat and continuously
which are based exclusively on measurements between
two limbs and effected with a pair of distal electrodes on
each limb. The measurement is made by causing an al-
ternating current to flow between one electrode of each
limb and measuring the potential difference between the
other two electrodes, one also on each limb. This poten-
tial difference has a low frequency component which is
the electrocardiogram (or ECG) and another component
having the frequency of the injected alternating current
and from which the so-called impedance plethysmogram
(IPG) is extracted. The cardiovascular information will be
determined by measuring the time interval between any
predefined characteristic element of the ECG and one of
the IPG.
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Description
Field of the Art
[0001] Measuring and control instrumentation. The
present invention relates in general to physiological pa-
rameter measuring and monitoring systems by noninva-
sive physical means
State of the Art
[0002] Obtaining information on cardiovascular pa-
rameters is of great importance for ascertaining people’s
state of health The availability of an apparatus which can
obtain said information beat by beat continuously, simply
and comfortably, without requiring the user themselves
or an assistant to have any specific abilities or training,
is of great interest. Particularly, when the measurements
are not taken in clinical or health care environment it is
very desirable for the subject not to need any aid to be
able to take the measurement.
[0003] Among the noninvasive measures providing in-
formation on the cardiovascular system, the bioelectric
signal measurements are some of the easiest to obtain,
above all if taken with dry electrodes (without conducting
gel). This practice limits the measuring areas to the limbs
(arms and legs) because the mechanical contact with the
electrodes may be made by fixing them or holding them
in the hand or resting the hands or feet on them. The
application of electrodes to other parts of the body, the
thorax for example, requires them to be held with means
achieving a sufficient pressure to guarantee a good con-
tact, which involves an obvious inconvenience and re-
quires time for placing them.
[0004] Two bioelectric signals that provide information
on the cardiovascular system are the electrocardiogram
(or ECG) and the electrical impedance signals measured
in volumes of the body where there is a variation attrib-
utable to the blood flow. The measurement of volume
changes (plethysmography) based on measuring the
electrical impedance is called impedance plethysmogra-
phy (IPG). Plethysmography based on measuring the
light absorbency is called photoplethysmography (PPG)
[0005] The ECG and IPG provide information on the
cardiovascular system not only separately but also joint-
ly. To be precise, the time taken by the arterial pulse
wave (involving a simultaneous change of volume) to
reach a part of the body depends not only on the distance
between said part and the heart, but it also depends on
the diameter, thickness and stiffness of the arteries, and
on the rheological properties of the blood. A time includ-
ing said information is the one known as PAT (pulse ar-
rival time), which is of great diagnostic interest, see, for
example, Eliakim et al, Pulse wave velocity in healthy
subjects and in patients with various disease states,
American Heart Journal, vol. 82, n° 4, pp 448-457, Oc-
tober 1971. Particularly, the PAT measured between the
R wave of the ECG and the foot (starting point of the
rapid rise associated with the ventricular systole) of the
photoplethysmography (PPG) in a finger of one hand is
frequently used to estimate the systolic pressure, for ex-
ample, as described by Chen et al., in "Continuous esti-
mation of systolic blood pressure using the pulse arrival
time and intermittent calibration"; Medical and Biological
Engineering and Computing, vol. 38, pp. 569-574, 2000.
Since both the PPG and the IPG measure changes of
volume, the wave forms of both signals are analogous,
and therefore the IPG has been used as an alternative
signal to the PPG to measure time intervals related with
the propagation of the pulse wave in the arteries.
[0006] In the document by Bang et al. "A pulse transit
time measurement method based on electrocardiogra-
phy and bioimpedance" Biomedical Circuits and Systems
Conference (BioCAS) 2009, pp. 153-156 the time
elapsed between the ECG R wave, obtained with an elec-
trode on each arm, and the IPG peak, obtained with four
electrodes on the forearm, was measured and this time
was compared with the time elapsed between the ECG
R wave and the PPG peak. The correlation between both
times was excellent. Although this method proposed by
Bang et al. has the advantage of not requiring electrodes
on the thorax, the use of conventional electrodes (with
conducting gel) adhered to the arm to obtain the ECG
and IPG makes the process slow and uncomfortable.
[0007] Another document where the measuring of
physiological parameters by the ECG and IPG without
of necessity locating electrodes on the thorax is de-
scribed in US patent 6,228,033 for Apparatus and meth-
ods for a noninvasive measurement of physiological pa-
rameters, to Kööbi et al., 2001. In this patent the IPG is
preferably obtained by injecting a current between both
arms and both legs at the same time, and detecting also
at the same time between both arms and both legs, as
shown in Figure 1, where the injection electrodes are the
pair 31 and the pair 32, and the detection electrodes are
the pair 11 and the pair 12 which, in a preferred embod-
iment described in the same document, are 5 cm from
the injection ones. With these electrode connections, it
is stated in said patent that the IPG obtained reflects
above all the overall impedance changes between arms
and legs, which will be proportional to the pumping out
of blood from the left ventricle. To obtain a distal pulse
wave, Kööbi et al. obtain the IPG in a segment of one
limb, by using a further two electrodes (21 and 22). They
obtain the ECG with the same electrodes (pair 11 and
pair 12) with which there is detected the potential differ-
ence created by the injected current to measure the im-
pedance without needing thoracic electrodes. The same
document describes that the injection of current to obtain
the overall IPG is always at least between one arm and
one leg; a possible arrangement of the electrodes ac-
cording to this embodiment is the one shown in Figure 2
where the injection is through the electrode 31 and elec-
trode 32 and the detection is through the electrode 11
and the electrode 12. However, according to Kööbi et al,
even in this embodiment wherein injection occurs only
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through one arm and one foot, to obtain the distal pulse
wave by the IPG in a segment of one limb a further two
detection electrodes (21 and 22) disposed along said
segment are still necessary. It is concluded, therefore,
that according to the method described in US patent
6,228,033 simultaneously to obtain a distal pulse wave
and the ECG, at least six electrodes are required, al-
though there is obtained also another IPG basically re-
flecting the impedance changes in the thorax. To obtain
the transit time of the pulse wave to a distal segment,
they calculate the distance between the peaks of both
impedance signals obtained, one from the voltage de-
tected between the electrode 11 and the electrode 12
(Figure 2) or between the pair of electrodes 11 and the
pair of electrodes 12 (Figure 1) and the other from the
voltage detected between the electrodes 21 and 22.
[0008] On the other hand, this Kööbi et al. patent is
contemplated for clinical environments and perhaps for
this reason they consider the possibility of using elec-
trodes with gel as an advantage, since they are common
in electrocardiography. In fact, the four electrodes at least
necessary for the limbs (11, 12, 31 and 32 in Figure 2)
could be replaced by dry electrodes. On the other hand,
if the two electrodes (21 and 22 in Figure 2) required for
obtaining a local pulse wave by the IPG in a segment of
a limb were dry, they would have to be held in place by
a strap or other similar means. Furthermore the need
always to have a connection with at least one arm and
one leg does not favour the design of a system so com-
pact as may be one needing only both hands or both feet.
[0009] The use of electrodes on the limbs and on dif-
ferent parts of the thorax to measure therebetween the
overall electrical impedance and the electrical imped-
ance at different sections of the body, and the changes
thereof over time is also described in the document WO
2005/010640 "Non-invasive multi-channel monitoring of
hemodynamic parameters" to Tsoglin and Margolin,
2005. But, to measure the peripheral blood flow they use,
for example, additional electrodes on one finger (pag. 13
and Figures 1, 2I, 3A, 3B, 3C, 4C and 5). Furthermore,
in this Tsoglin and Margolin document, although some
of the electrodes used for measuring the bioimpedance
are also used to obtain the ECG, they do not do so si-
multaneously, but the apparatus includes a switching cir-
cuit (member 29 in Figure 6 of the document) connecting
the electrodes for carrying out one function or the other,
but never both together, whereby it is not possible to ob-
tain cardiovascular information from the combination of
the simultaneous measurements of both.
[0010] The method and apparatus proposed in the in-
vention described hereinafter allow the ECG and a distal
pulse wave to be obtained using only two pairs of elec-
trodes, dry or otherwise, it being sufficient for one pair to
be in contact with each of the two upper limbs or with
each of the two lower limbs, although also one pair may
be disposed on one arm and the other pair on one leg,
either on the same side or on opposite sides of the body.
Description of the Invention
[0011] The present invention allows information on the
cardiovascular system to be obtained beat by beat and
continuously, by measuring only between two limbs with
one pair of distal electrodes on each of them. To this end,
an alternating current is injected between both limbs and
the potential difference is measured between two elec-
trodes, each being adjacent one of the two injection elec-
trodes.
[0012] Referring to Figure 3, the excitation signal 300
is an alternating current which is caused to flow between
an electrode A which is on a distal segment of one limb
and an electrode B which is on a distal segment of another
limb. A further two electrodes C and D detect the potential
in areas respectively close to each of the injection elec-
trodes, and the potential difference between them is de-
tected by the circuit 310. The first pair of electrodes 301
is on one limb and the second pair 302 is on another limb.
[0013] The voltage at the detector 310 inlet has two
components: one low frequency component (less than
40 Hz) which is the electrocardiogram (or ECG), gener-
ated by the body itself owing to the electrical activity of
the heart, and a component having the frequency of the
injected alternating current and the amplitude of which
depends on the electrical impedance in the conducting
volume through which said current flows. Said imped-
ance has a continuous component of great relative am-
plitude, due to the basal electrical impedance between
the limbs being measured, which will remain constant,
and a much smaller variable component, due to the car-
diovascular activity. The registration of this variable com-
ponent of the electrical bioimpedance is the so-called
impedance plethysmogram (IPG). Therefore, the IPG
and the ECG may be separated at the detector 310 outlet
and each of these signals can be amplified by means of
respective conventional circuits 320 and 330.
[0014] In their article "Sources of error in tetrapolar im-
pedance measurements on biomaterials and other ionic
conductors" published in the Journal of Physics D: Ap-
plied Physics, vol. 40, pp. 9-14, 2007, Grimnes and Mar-
tinsen warn that it would be erroneous to assume that
when measuring with four electrodes the impedance is
determined only by the volume between the detection
electrodes and show that the volume between the injec-
tion electrodes and the detection electrodes also contrib-
utes to the impedance. Thus, the measured impedance
will be the sum of the impedance of all the segments
between the electrodes, each one weighted depending
on the intrinsic electrical properties of each segment and
its section, those of smaller section being the ones that
will have a greater contribution to the total impedance
measured.
[0015] When measuring between the distal segments
of two limbs, the conducting volume between the injection
electrodes is constituted by each limb and the thorax.
Owing to its relative transversal dimensions, it is to be
expected that the thoracic impedance is much smaller
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than that of the limbs. Effectively, S. Grimnes, in Table
3 of his article "Impedance measurement of individual
skin surface electrodes" in Medical and Biological Engi-
neering and Computing, vol. 21, pp. 750-755, 1983,
shows that the impedance between the breastbone and
the middle of the thigh is one third of the impedance be-
tween the breastbone and the centre of the upper arm
one seventh of the impedance of one arm and one tenth
of the impedance of a finger. With this data, since in this
invention each electrode pair is disposed on the distal
segments of a limb, it is to be expected that a major por-
tion of the impedance obtained is due to the limb tissues,
the section of which is much smaller than that of the tho-
rax. Bearing in mind the abundant presence of arteries
in the hands and in the feet, said local impedances will
change with each beat due to the arrival of the arterial
pressure pulse and the consequent volume change. Ow-
ing to the breathing and to the ejection of blood from the
heart on each beat the thoracic impedance will also
change, but since its section is much larger, the sensitivity
of the electrodes to these changes at the thorax will be
much lower than the sensitivity to the changes at the
limbs themselves due to the arterial pressure wave.
[0016] Once the ECG and the IPG have been digitized,
the propagation time of the pulse wave may be calculated
by measuring the interval between the R wave of the
ECG, for example, and a predefined element of the puls-
ing component of the impedance, such as the onset of
its rapid variation, the point of maximum amplitude
(peak), an intermediate point between both (for example,
the one corresponding to 10% or 50% of the pulse am-
plitude), the maximum gradient point, or any other con-
venient element. These times are related to the elasticity
of the arteries and the arterial pressure.
[0017] The identification and combination of the pre-
defined elements in the ECG and the IPG may be effected
by a processor 340 or an expert using cursors on the
display monitor 350. The processor may also calculate
the amplitude of certain predefined points of the IPG, and
with these amplitudes indices and parameters analogous
to those defined in the literature for the equivalent points
in the arterial pressure wave, and additional parameters
which aid better to characterize the pulse wave form may
be defined. The diagnostic value of the indices and pa-
rameters traditionally defined for the pressure wave in
the cardiovascular system is well documented, for exam-
ple in the book "McDonald’s blood flow in arteries" edited
by W.W. Nichols and M. F. O’Rourke and published by
Hodder Arnold (London), 2005. Particularly, said indices
are used to noninvasively assess the stiffness of the ar-
teries. (See for example the publications "Noninvasive
assessment of arterial stiffness and risk of atherosclerotic
events" by Oliver and Webb in Arteriosclerosis, Throm-
bosis, and Vascular Biology, vol. 23, pp. 554-566, 2003,
and "Arterial stiffness and cardiovascular events: the
Framingham heart study" by Mitchell et al., in Circulation,
vol. 121, pp. 505-511, 2010). With the present invention,
it is possible to calculate said indices and parameters in
signals obtained by measuring with only four electrodes
between both hands, between both feet, or between one
hand and one foot, either on the same side of the body
or on opposite sides.
[0018] Since in this method there is no need to apply
electrodes on the body trunk or necessarily on segments
of the limbs, but the contact with the electrodes may be
made with the hands or feet, there is obtained the ad-
vantage of being able to use dry electrodes. Thus, the
contact with them may be made, for example, with the
fingers of the hands or with the soles of the feet, to men-
tion two cases particularly comfortable for the user. But
the proposed method does not of itself demand that the
electrodes should be dry, but that they may use a con-
ducting gel, for example on persons where, because
some member has been amputated, the most distal end
of a limb is a stump. However, if the electrodes are located
on the body, the variability of their position is much wider
than that had when the electrodes are on a surface with
which a limb has to make contact, particularly if the con-
tact is made with the fingers. Since the position of the
electrodes affects the IPG wave form, guaranteeing that
the position of the contacts is always the same is an im-
portant advantage.
Brief Description of the Drawings
[0019]
Figure 1 shows the arrangement of the electrodes
described in a preferred embodiment of US patent
6,228,033, the designation of the electrodes being
the same as in the original document.
Figure 2 shows the arrangement of the electrodes
in a derivative embodiment of the preferred embod-
iment described in US patent 6,228,033, the desig-
nation of the electrodes being the same as in the
original document.
Figure 3 is a block diagram of the proposed meas-
uring method.
Figure 4 shows a preferred embodiment of the meth-
od described in this invention.
Figure 5 shows the ECG and IPG obtained with the
preferred embodiment of Figure 4.
Figure 6 shoes the evolution of the PAT measured
with the proposed method (solid line) and the PAT
measured with the conventional method (from the R
wave of the ECG to a point of the PPG (photoplethys-
mogram)) along a periodic respiration at a rate of six
respirations per minute.
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Description of a preferred embodiment of the inven-
tion
[0020] Figure 4 shows a preferred embodiment of the
measuring method described and shown with the dia-
gram of Figure 3. In this preferred embodiment, both the
electrode pair 301 and the electrode pair 302 are two
copper sheets and both pairs are disposed on a common
surface which the user holds with his/her hands, in such
a way that the index finger of the right hand 401 is in
contact with the electrode A of the pair 301 and the middle
finger of the same hand is in contact with the electrode
C of the same pair 301. At the same time, the index finger
of the left hand 402 is in contact with the electrode B of
the pair 302 and the middle finger of the same hand is in
contact with the electrode D of the same pair 302.
[0021] An alternating current source generates the ex-
citation signal 300 which is a sinusoidal current of 10 kHz
and 0.5 mA peak, injected between the electrodes A and
B; this second electrode B is connected to the signal earth
of the electronic input circuits of the apparatus. The elec-
trode C and electrode D are each connected to a unit
gain amplifier, the ensemble of which constitutes the de-
tector 310. The potential difference between the outlets
of these two amplifiers is measured with two circuits with
a differential input which are connected in parallel, one
to obtain the IPG and the other to obtain the ECG. In this
preferred embodiment, the circuit 320 for obtaining the
IPG consists of a high pass filter with differential input
and output, with cut-off frequencies of 1 kHz, followed by
a six gain instrumentation amplifier, an amplitude demod-
ulator based on a coherent detector formed by an ampli-
fier, the gain of which is periodically switched between
+1 and -1 synchronously with the carrier signal, a filter
allowing the frequency band of 0.05 Hz to 30 Hz to pass,
and a 14,000 gain output amplifier. The circuit 330 for
obtaining the ECG consists of a filter having differential
inlet and outlet allowing the frequency band of 0.05 Hz
to 100 Hz to pass, followed by an instrumentation ampli-
fier of 1000 gain and a low pass filter with a cut-off fre-
quency of 100 Hz. Both the IPG and the ECG are digitized
with a resolution of 16 bits and a sampling frequency of
10 kHz.
[0022] The specific elements defined for the ECG and
the IPG in this preferred embodiment are the R wave of
the ECG and the point on the rising flank of the IPG, the
amplitude of which is equidistant from the foot and the
peak of the impedance pulse.
RESULTS
[0023] Figure 5 shows the IPG and the ECG obtained
with the described preferred embodiment. It may be seen
that the peaks of the upper curve (the IPG) appear always
with a considerable delay relative to the peaks of the
lower curve, which are the R wave of the ECG. If the
detected impedance changes were those produced on
the thorax, the IPG peaks would appear shortly after the
R wave, since this coincides with the ventricular systole
and the consequent expulsion of blood from the heart.
The long delay between the IPG peak and the ECG R
wave confirms the advantage of the electrode arrange-
ment proposed in this invention, where the injection elec-
trodes are at a distal end of each of two limbs and the
detection electrodes are close to the injection ones.
[0024] To verify that the PAT interval measured be-
tween the two predefined points of the ECG and IPG
signals, and identified in the preferred embodiment of
this invention, are related to the changes in the propa-
gation in the pulse wave, there has been carried out an
experiment consisting of breathing with an approximately
periodic frequency and comparing the PAT between the
ECG and the IPG obtained with the method described in
this invention with the PAT between the same ECG and
IPG obtained with a commercial photoplethysmograph
disposed on the ring finger of one hand; to be precise,
the PAT was measured between the R wave and the
point on the rising flank of the PPG, the amplitude of
which is that of the foot of the PPG plus 10% of the dif-
ference between the peak and the foot of the PPG. It is
well known that both the propagation velocity of the pulse
wave and the arterial pressure depend on the breathing,
since this causes variation in the intrathoracic pressure.
Figure 6 shows that, on breathing at about 0.1 Hz (ap-
proximately 6 inhalations per minute) the fluctuations in
the PAT measured between the ECG and the IPG coin-
cide closely approximately with the fluctuations of the
PAT measured between the ECG and the PPG. The cor-
relation coefficient between both signals displayed is
0.93.
[0025] Having sufficiently described the invention, as
well as a preferred embodiment, it should only be added
that it is possible to make modifications in its constitution,
materials used and in the form and dimensions of the
electrodes, without deviating from the scope of the in-
vention defined in the following claims.
Claims
1. A method for obtaining information on the cardiovas-
cular system non-invasively, continuously and beat
by beat, characterized in that:
a) a current is injected and potential differences
are measured between two limbs, using a total
of four electrodes which are, for each limb, one
injector electrode and one measuring electrode
close to each other and located on a distal seg-
ment thereof.
b) the ECG is obtained from the measurement
between the two limbs.
c) the impedance plethysmogram (IPG) is ob-
tained from the same measurement between
the two limbs.
d) specific predefined elements in the ECG and
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IPG are identified.
e) time intervals between the specific elements
identified in the ECG and IPG signals are meas-
ured.
f) cardiovascular information is estimated from
said time intervals.
2. The method of claim 1, characterized in that the
electrodes of one pair make contact with two points
of one hand and the electrodes of the other pair make
contact with two points of the other hand.
3. The method of claim 1, characterized in that the
electrodes of one pair make contact with two points
of one foot and the electrodes of the other pair make
contact with two points of the other foot.
4. The method of claim 1, characterized in that the
electrodes of one pair make contact with two points
of one hand and the electrodes of the other pair make
contact with two points of one foot.
5. An apparatus for obtaining information on the cardi-
ovascular system non-invasively, continuously and
beat by beat, and containing:
a) two pairs of electrodes, one electrode of each
pair being a measuring electrode and the other
a current injection electrode, both electrodes be-
ing close together.
b) a current injection system.
c) a system for measuring potential differences.
d) a system for separating in the voltages meas-
ured the component coming from the electrocar-
diogram from the one coming from the injected
current.
e) a calculation system obtaining cardiovascular
information from the combination of the informa-
tion coming from the electrocardiogram and that
coming from the injected current.
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